Fluid management in acute respiratory distress syndrome

Current Opinion in Critical Care

Volumn 2, Issue 1, 1996, Pages 1-7

  Schuller, Dan ^a   Schuster, Daniel P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344017387     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-199602000-00001     Document Type: Review

References (60)

1. Schuster DP: What is acute lung injury? What is ARDS? Chest 1995, 107:1721-1726. This article discusses the consensus conference definitions of the terms acute lung injury, diffuse alveolar damage, and ARDS. A figure in this article includes the reported mortality in 14 different ARDS trials showing a decreasing mortality trend.
2. 1 followed by a thorough discussion of specific pharmacologic and nonpharmacologic measures including experimental therapies for ARDS.
3. Hudson LD: New therapies for ARDS. Chest 1995, 108:79S-91S. Excellent up-to-date review of all supportive therapies as well as anti-inflammatory strategies.
4. Holzapfel L, Robert D, Perrin F, Gaussorgues P, Giudicelli DP: Comparison of high frequency jet ventilation to conventional ventilation in adults with respiratory distress syndrome. Intensive Care Med 1987, 13:100-105.
5. Zapol WM, Snider MT, Hill JD, et al.: Extracorporeal membrane oxygenation in severe acute respiratory failure. JAMA 1979, 242:2193-2196.
6. 2 removal for ARDS. Trans Am Soc Artif 1988, 11:48-53.
7. Bernard GR, Luce JM, Sprung CL, Rinaldo JE: High dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987, 317:1565-1570.
8. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF: Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988, 138:62-68.
9. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA: Early methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Chest 1987, 92:1032-1046.
10. Jepsen S, Herlevsen P, Bud MI, Dlaussen NO: Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med 1992, 20:918-923.
11. 1 in patients without the adult respiratory distress syndrome. Chest 1989, 96:114-119.
12. Matthay MA: Pathophyslology of pulmonary edema. Clin Chest Med 1985, 6:301-312.
13. Zwinkler MP, Peters TM, Michel RP: Effects of pulmonary fibrosis on the distribution of edema: computed tomographic scanning and morphology. Am J Respir Crit Care Med 1994, 149:1266-1275. This paper shows that in an experimental model of pulmonary fibrosis, there is predominant alveolar flooding over interstitial edema due to distribution of edema fluid away from less compliant interstitium.
14. Matthay MA, Wiener-Kronish JP: Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990, 142:1250-1257.
15. Prewitt RM, McCarthy J, Wood LDH: Treatment of acute low pressure pulmonary edema in dogs: relative effects of hydrostatic and oncotic pressure, nitroprusside, and positive end-expiratory pressure. J Clin Invest 1981, 67:409-418.
16. Huchon GJ, Hopewell PC, Murray JF: Interactions between permeability and hydrostatic pressure in perfused dogs' lungs. J Appl Physiol 1981, 50:905-911.
17. Molloy WD, Lee KY, Girling L, Prewitt RM: Treatment of canine permeability pulmonary edema: short-term effects of dobutamine, furosemide, and hydralazine. Circulation 1985, 72:1365-1371.
18. Townsley MI, Lim EH, Sahawneh TM, Song W: Interaction of chemical and high vascular pressure injury in isolated canine lung. J Appl Physiol 1990, 69:1647-1664.
19. Allen SJ, Drake RE, Katz J, Gabel JC, Laine GA: Lowered pulmonary arterial pressure prevents edema after endotoxin in sheep. J Appl Physiol 1987, 63:1008-1011.
20. Berner ME, Teague WG, Scheerer RG, Blanel RD: Furosemide reduces lung fluid filtration in lambs with lung microvascular injury from air emboll. J Appl Physiol 1989, 67:1990-1996.
21. Long R, Breen PH, Mayers I, Wood LD: Treatment of canine aspiration pneumonitis: fluid volume reduction vs. fluid volume expansion. J Appl Physiol 1988, 65:1736-1744.
22. Sznajder JI, Zucker AR, Wood LDH, Long GR: The effects of plasmapheresis and hemofiltration on canine acid aspiration pulmonary edema. Am Rev Respir Dis 1986, 134:222-228.
23. Winn R, Strothert J, Nadir B, et al.: Lung fluid balance, vascular permeability, and gas exchange after acid aspiration in awake goats. J Appl Physiol 1984, 56:979-985.
24. Zucker AR, Sznajder JI, Becker CJ, et al.: The pathophysiology and treatment of canine kerosene pulmonary injury: effects of plasmapheresis and positive end-expiratory pressure. J Crit Care 1989, 4:184-193.
25. Sivak ED, Tita J, Meden G, Ishigami M, Graves J, Kavlich J, Stowe NT, Magnusson MO: Effects of furosemide versus isolated ultrafiltration on extravascular lung water in oleic acid-induced pulmonary edema. Crit Care Med 1986, 14:48-51.
26. Chernicki JAW, Wood LDH: Effect of furosemide in canine low-pressure pulmonary edema. J Clin Invest 1979, 64:1494-1504.
27. Schuster DP: ARDS: clinical lessons from the oleic acid model of acute lung injury. Am J Respir Crit Care Med 1994, 149:245-260. State-of-the-art review of one of the most popular animal models of acute lung injury, including a discussion of the mechanisms of lung dysfunction, the cardiopulmonary effects, and a comparison with human ARDS.
28. Schuster DP, Haller J: A quantitative correlation of extravascular lung water accumulation with vascular permeability and hydrostatic pressure measurements: a positron emission tomography study. J Crit Care 1990, 5:161-168.
29. Ali J, Unruh H, Skoog C, et al.: The effect of lung edema on pulmonary vasoactivity of furosemide. J Surg Res 1983, 35:383-390.
30. Ali J, Wood LDH: Pulmonary vascular effects of furosemide on gas exchange in pulmonary edema. J Appl Physiol 1984, 57:160-167.
31. Stevens EL, Uyehara CFT, Southgate WM, Nakamura KT: Furosemide differentially relaxes airway and vascular smooth muscle in fetal, newborn, and adult guinea pigs. Am Rev Respir Dis 1992, 146:1192-1197.
32. Rusch VW, Artman L, Cheney FW: Effect of furosemide on fully established low pressure pulmonary edema. J Surg Res 1986, 41:141-145.
33. Cheney FW, Bishop MJ, Chi EY, Listenstein BL: Effect of regional alveolar hypoxia on permeability pulmonary edema formation in dogs. J Appl Physiol 1987, 62:1690-1697.
34. Bishop MJ, Boatman ES, Webster R, Ivey TD, Cheney FW Jr: Effects of lobar pulmonary blood flow on the evolution of oleic acid lung injury in dogs. J Surg Res 1986, 41:394-400.
35. Dauber IM, Weil JV: Lung injury edema in dogs: influence of sympathetic ablation. J Clin Invest 1983, 72:1977-1986.
36. Leeman M, Closset J, Vachiery J, Lejeune P, Melot C, Naeije R: Sino-aortic deafferentation reduces intrapulmonary shunt in dogs with oleic acid lung injury. J Appl Physiol 1989, 67:833-838.
37. Hasinoff I, Ducas J, Prewitt RM: Increased cardiac output increases lung water in canine permeability pulmonary edema. J Crit Care 1988, 3:225-231.
38. Takeda K, Knapp MJ, Wolfe WG, Capo JD: Hypoxia enhances unilateral lung injury by increasing blood flow to the injured lung. J Appl Physiol 1987, 63:2516-2523.
39. Bone RC: Treatment of adult respiratory distress syndrome with diuretics, dialysis, and positive end-expiratory pressure. Crit Care Med 1978, 6:136-139.
40. Costello JL, Dorinksy PM, Gadek JE: Edema reduction improves clinical abnormalities in ARDS: a clinical trial of aggressive diuretic therapy [abstract]. Am Rev Respir Dis 1987, 135:A9.
41. Simmons RS, Berdine GG, Seidenfeld JJ, Prihoda TJ, Harris GD, Smith JD, Gilbert TJ, Mota E, Johanson WG Jr: Fluid balance and the adult respiratory distress syndrome. Am Rev Respir Dis 1987, 135:924-929.
42. Humphrey H, Hall J, Sznajder I, Silverstein M, Wood L: Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990, 97:1176-1180.
43. Lowell JA, Schifferdecker C, Discoll DF, Benotti PN, Bistrian BR: Postoperative fluid overload: not a benign problem. Crit Care Med 1990, 18:728-733.
44. Eisenberg PR, Hansbrough JR, Anderson D, Schuster DP: A prospective study of lung water measurements during patient management in an intensive care unit. Am Rev Respir Dis 1987, 136:662-668.
45. Mitchell JP, Schuller D, Calandrino FS, et al.: Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis 1992, 145:990-998.
46. Schuller D, Mitchell JP, Calandrino FS, Schuster DP: Fluid balance during pulmonary edema: is fluid gain a marker or a cause of poor outcome. Chest 1991, 100:1068-1075.
47. Packman MI, Rackow EC. Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 1983, 11:165-169.
48. Ognibene FP, Parker MM, Natanson C, Shelhamer JH, Parrillo JE: Depressed left ventricular performance: response to volume infusion in patients with sepsis and septic shock. Chest 1988, 93:903-910.
49. Schuster DP: The case for and against fluid restriction and occlusion pressure reduction in adult respiratory distress syndrome. New Horiz 1993, 1:478-488.
50. Schuster DP: Fluid management in ARDS: "keep them dry" or does it matter? Intensive Care Med 1995, 21:101-103.
51. Hyers TM: ARDS: the therapeutic dilemma. Chest 1990, 97:1025.
52. Sznajder I. Beneficial effects of reducing pulmonary edema in patients with hypoxemic respiratory failure. Chest 1990, 100:890-891.
53. Hudson LD: Fluid management strategy in acute lung injury. Am Rev Respir Dis 1992, 145:988-989.
54. Schuller D, Lynch JP: Prospective, randomized, comparative trial of continuous vs. bolus furosemide infusion in the intensive care unit [abstract]. Chest 1994, 106:157S. Preliminary observations of the benefits of protocol-driven diuresis and fluid management in the ICU.
55. Hull RD, Raskob GE, Rosenbloom D, Lemaire J, Pineo GF, Bayliss B, et al.: Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992, 152:1589-1595.
56. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S: The weight-based heparin dosing nomogram compared with a "standard care" nomogram. Ann Intern Med 1993, 119:874-881.
57. 2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994, 149:295-305.
58. Tuchschmidt J, Fried J, Astiz M, Rackow E: Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992, 102:216-220.
59. 2 removal, protocol control of intensive care unit care, and the human laboratory. J Crit Care 1992, 7:280-286.
60. Reinersten JL: Algorithms, guidelines, and protocols: can they really improve what we do [editorial]? Transfusion 1994, 34:281-282. Excellent editorial that highlights the phases and importance of algorithm implementation.